COVID-19 Key EU Developments, Policy & Regulatory Update No. 55

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
This regular update (no. 55 | 12 July 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices...
European Union Antitrust/Competition Law
To print this article, all you need is to be registered or login on Mondaq.com.

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • European Commission publishes 2020 Report on Competition Policy
  • European Commission adopts positive assessments of Recovery and Resilience Plans from an additional 2 Member States, and EU finance ministers give green light to first disbursements
  • European Commission approves new and amended Member State measures to support the economy

Trade / Export Controls

  • European Parliament adopts Report on post-COVID trade strategy

Medicines and Medical Devices

  • No noteworthy developments for this issue

Cybersecurity, Privacy & Data Protection

  • European Commission adopts equivalence decision for Swiss COVID digital certificates
  • EU and UK discuss interoperability of EU Digital COVID Certificates

To view the full article, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More